Mechanism & research context
Retatrutide is an investigational tri-agonist peptide engaging GIP, GLP-1 and glucagon receptors. Preclinical research explores combined receptor activation on lipolysis, thermogenesis and hepatic glucose output. Supplied as lyophilized powder at ≥98% HPLC purity.
Use disclaimerFor Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Article reflects published preclinical and in-vitro literature. Additional citations available on request to research@peptitan.eu.